Catalyst Wire Dossier Catalyst Wire Dossier

Estetrol 15 mg / Drospirenone 3 mg (combined oral contraceptive)

estetrol/drospirenone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Estetrol 15 mg / Drospirenone 3 mg (combined oral contraceptive), covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: "Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition [NA]

See pricing